# Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU

> **NCT07481773** · NA · RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 1200 (estimated)

## Conditions studied

- Intensive Care Unit (ICU) Admission

## Interventions

- **DIAGNOSTIC_TEST:** Biomarker-signature supported antibiotic treatment recommendation
- **DIAGNOSTIC_TEST:** Clinical assessment for antibiotic treatment decision

## Key facts

- **NCT ID:** NCT07481773
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2028-05
- **Final completion:** 2028-08
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07481773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07481773, "Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07481773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*